Meeting
2023 ASCO Quality Care Symposium
Prediction model for real-world survival in men with castration-resistant prostate cancer and bone metastases in the United States: A real-world database study.
Authors
Amit D Raval
Bayer HealthCare Pharmaceuticals, Whippany, NJ
Amit D Raval, Jordi Casanellas, Orsolya Lunacsek, Niculae Constantinovici, Per Sandstrom
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Health Care Access, Equity, and Disparities,Technology and Innovation in Quality of Care,Palliative and Supportive Care
Sub Track
Decision Support Tools
Citation
JCO Oncol Pract 19, 2023 (suppl 11; abstr 507)
DOI
10.1200/OP.2023.19.11_suppl.507
Abstract #
507
Poster Bd #
K10
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Evaluating generalizability of practice-changing randomized clinical trials in non-small cell lung cancer using machine learning-based in-silico trials.
First Author: Xavier Orcutt
Poster
2022 ASCO Annual Meeting
Using machine learning on real-world data to predict metastatic status.
First Author: Foad H. Green
Poster
2022 ASCO Annual Meeting
Machine learning application to find patients with lower-risk myelodysplastic syndrome from real-world data.
First Author: Colden Johanson
Poster
2020 ASCO Virtual Scientific Program
Predicting the risk of VISIT emergency department (ED) in lung cancer patients using machine learning.
First Author: Pablo Rodriguez-Brazzarola